Харьковская Медицинская Академия Последипломного Образования
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківська Медична Академія Післядипломної Освіти, Харьковская Медицинская Академия Последипломного ОбразованияfiledCriticalХарківська Медична Академія Післядипломної Освіти
Priority to UAU200506005UpriorityCriticalpatent/UA11281U/en
Publication of UA11281UpublicationCriticalpatent/UA11281U/en
The method for treating neurangiosis of hypertonic type comprises magnetotherapy. The cardiac area is exposed to the low frequency alternate sinusoidal magnetic field at C4-Th6 level using two cylindrical inducers with the intensity of 35 mT, exposition time 10 minutes, daily, 10 procedures in total.
UAU200506005U2005-06-172005-06-17Method for treating neurangiosis of hypertonic type
UA11281U
(en)
4-A5-METHOXY-6- (2-METHYL-6-E1,2,4-UTRIAZOL-1-YL-PYRIDIN-3-YLAMINO) -PYRIMIDINE-4-YLOXY-PIPERIDIN-1-CARBOXYLIC ACID ISOPROPYL ESTER AS METABOLIC MODULATORS AND TREATMENT OF THUS ASSOCIATED DISEASES